TLX · Telix Pharmaceuticals Ltd
$11.75
-0.07 (-0.59%)
At close · Aug 17
Market Cap
$4.00B
Shares
338.78M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-29 | 1,406 | $10.19 | $14,327 |
| 2026-07-27 | 640 | $10.22 | $6,541 |
| 2026-07-23 | 600 | $10.32 | $6,192 |
| 2026-07-22 | 11,638 | $10.92 | $127,087 |
| 2026-07-21 | 11,062 | $10.51 | $116,262 |
| 2026-07-20 | 3,709 | $10.46 | $38,796 |
| 2026-07-17 | 2,363 | $10.83 | $25,591 |
| 2026-07-16 | 416 | $11.29 | $4,697 |
| 2026-07-15 | 76 | $11.02 | $838 |
| 2026-07-13 | 2,300 | $11.14 | $25,622 |
| 2026-07-10 | 7,009 | $11.78 | $82,566 |
| 2026-07-09 | 2,000 | $11.55 | $23,100 |
| 2026-07-08 | 2,300 | $11.74 | $27,002 |
| 2026-07-02 | 417 | $11.84 | $4,937 |
| 2026-07-01 | 493 | $11.53 | $5,684 |
| 2026-06-30 | 49,539 | $11.30 | $559,791 |
| 2026-06-29 | 1,272 | $10.66 | $13,560 |
| 2026-06-26 | 1,938 | $10.86 | $21,047 |
| 2026-06-25 | 2,547 | $10.90 | $27,762 |
| 2026-06-24 | 9,300 | $10.21 | $94,953 |
| 2026-06-18 | 84,999 | $9.94 | $844,890 |
| 2026-06-17 | 106,190 | $9.58 | $1,017,300 |
| 2026-06-16 | 2,297 | $9.54 | $21,913 |
| 2026-06-15 | 135,403 | $9.56 | $1,294,453 |
| 2026-06-12 | 55,507 | $9.45 | $524,541 |
| 2026-06-08 | 554 | $9.30 | $5,152 |
| 2026-06-05 | 5,403 | $9.54 | $51,545 |
| 2026-06-04 | 293 | $8.77 | $2,570 |
| 2026-06-03 | 400 | $9.16 | $3,664 |
| 2026-05-29 | 9,773 | $9.53 | $93,137 |
| 2026-05-28 | 3,100 | $9.74 | $30,194 |
| 2026-05-27 | 3,000 | $9.57 | $28,710 |
| 2026-05-26 | 510 | $9.47 | $4,830 |
| 2026-05-22 | 20,087 | $10.27 | $206,293 |
| 2026-05-21 | 18,840 | $10.28 | $193,675 |
| 2026-05-20 | 10,974 | $10.17 | $111,606 |
| 2026-05-19 | 246 | $10.28 | $2,529 |
| 2026-05-18 | 7,047 | $10.56 | $74,416 |
Showing 1–38 of 38 settlements
Key facts
CIK
2007191
CUSIP
87961M105
13F (30d)
58 filings
58 filers
Visit website
Investor relations